Asahi Kasei Pharma Corporation
Asahi Kasei Pharma Corporation, a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and North America. Founded in 1941, the company has established itself as a leader in innovative healthcare solutions, focusing on prescription pharmaceuticals, regenerative medicine, and diagnostic products. With a commitment to advancing medical science, Asahi Kasei Pharma is renowned for its unique offerings, including cutting-edge therapies for cardiovascular and metabolic diseases. The company’s dedication to research and development has led to significant milestones, positioning it as a trusted name in the global market. Asahi Kasei Pharma continues to enhance patient care through its high-quality products and a strong emphasis on sustainability and ethical practices.
DitchCarbon Score
How does Asahi Kasei Pharma Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Asahi Kasei Pharma Corporation's score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Asahi Kasei Pharma Corporation's reported carbon emissions
Asahi Kasei Pharma Corporation, headquartered in Japan (JP), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is unclear how their operations impact the environment in terms of Scope 1, 2, or 3 emissions. The absence of documented reduction initiatives or climate pledges suggests that the company may not have publicly committed to specific climate action goals at this time. Asahi Kasei Pharma's approach to climate commitments remains vague, highlighting a potential area for improvement in transparency and accountability regarding their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asahi Kasei Pharma Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
